ArticleThe Lancet regional health. Western Pacific2021
Changes in the prevalence of obesity and hypertension and demographic risk factor profiles in China over 10 years: two national cross-sectional surveys.
Article in The Lancet regional health. Western Pacific, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
29 citing papers in PubMed.
- Spatial analysis of the association between convenience store density and the prevalence of obesity and hypertension in South Korea.Frontiers in public health · 2026Article
- National trends in the unmet healthcare needs among patients with hypertension or type 2 diabetes mellitus in Korea from 2009 to 2023.Scientific reports · 2025Article
- The individual and joint effects of long-term exposure to temperature and relative humidity on blood pressure: a prospective cohort study in China.BMC public health · 2025Article
- Trends and projections of heart failure among adolescents and young adults: an in-depth analysis for the Global Burden of Disease Study 2021.European heart journal. Quality of care & clinical outcomes · 2025Article
- The Relationship Between Personality and Self-Management Behavior in Chinese Young and Middle-Aged People with Chronic Illness: The Chain Mediating Role of Family Health and Health Literacy.Patient preference and adherence · 2025Article
- Prevalence and determinants of obesity and its association with upper gastrointestinal diseases in people aged 40-69 years in Yangzhong, southeast China.Scientific reports · 2024Article
- Missed opportunities for hypertension screening of older people in the Philippines: cross-sectional analysis of nationally representative individual-level data.The Lancet regional health. Western Pacific · 2024Article
- Risk factors for the neurodegenerative dementias in the Western Pacific region.The Lancet regional health. Western Pacific · 2024Review
- Branched-chain amino acids and the risk of hypertension; a persian cohort-based study.BMC cardiovascular disorders · 2024Article
- Association between obesity and the prevalence of dyslipidemia in middle-aged and older people: an observational study.Scientific reports · 2024Observational
- Changes in the prevalence of diabetes and control of risk factors for diabetes among Chinese adults from 2007 to 2017: An analysis of repeated national cross-sectional surveys.Journal of diabetes · 2024Article
- Trends in prevalence of obesity and its association with hypertension across socioeconomic gradients in rural Yunnan Province, China.BMC cardiovascular disorders · 2024Article
- Revisiting Waist Circumference: A Hypertension Risk Factor that Requires a More In-depth Understanding.Current cardiology reviews · 2024Review
- Analysis of prescription status of antihypertensive drugs in Chinese patients with hypertension based on real-world study.Annals of medicine · 2023Article
- Ultra-Processed Food Consumption and Risk of Overweight or Obesity in Chinese Adults: Chinese Food Consumption Survey 2017-2020.Nutrients · 2023Article
- Strategies to Improve Long-Term Outcomes for Patients with Chronic Kidney Disease in China.Kidney diseases (Basel, Switzerland) · 2023Review
- Association between the age at onset of overweight and obesity and the subsequent risk of hypertension in Chinese adults.BMC cardiovascular disorders · 2023Article
- Policy analysis of system responses to addressing and reversing the obesity trend in China: a documentary research.BMC public health · 2023Article
- Age-specific trend and birth cohort effect on different histologic types of uterine corpus cancers.Scientific reports · 2023Article
- Prevalence of Hypertension and Associated Factors among Residents Aged ≥18 Years in Ganzhou, China: A Cross-Sectional Study.International journal of hypertension · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPrevious studies have shown increases in the prevalence of obesity and hypertension, but nationally representative data on recent changes in prevalence adjusted for population structure changes are lacking. Two nationwide surveys were conducted in 2007 and 2017 to assess the prevalence changes of these conditions in China.
methodsA multistage stratified random sampling method was used to obtain a nationally representative sample of adults aged 20 years and older in mainland China in 2007 and 2017. Temporal changes in the prevalence of hypertension and obesity were investigated. Changes in blood pressure, body mass index (BMI) and waist circumference were also assessed. Logistic regression models were constructed to assess the changes in prevalence over time.
findingsThe weighted prevalence of hypertension (25.7% vs. 31.5%,
interpretationCompared with 2007, the prevalence of hypertension and obesity was significantly higher among adults in mainland China after adjusting for demographic confounding factors in 2017. More targeted interventions and prevention strategies are needed to offset the increasing risk of cardiovascular disease due to increases in the prevalence of hypertension and obesity.
fundingThe Clinical Research Fund of the Chinese Medical Association (Grant No. 15010010589), the National Natural Science Foundation of China (Grant No. 82000753), and the Chinese Medical Association Foundation and Chinese Diabetes Society (Grant No. 07020470055).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.